Activation of afferents to the ventral tegmental area in response to acute amphetamine: a double-labelling study.
The ventral tegmental area (VTA), primary source of the mesocorticolimbic dopaminergic system, is regarded as a critical site for initiation of behavioural sensitization to psychostimulants. The present study was undertaken to identify the neural pathways converging on the VTA that are potentially implicated in this process. Rats were sensitized by a single exposure to amphetamine (5 mg/kg, s.c.). The distribution of VTA-projecting neurons activated by amphetamine was examined by combining retrograde transport of the cholera toxin beta subunit (CTb), injected into the VTA, with immunodetection of Fos. The quantitative analysis of CTb-Fos double labelling demonstrates that amphetamine induced a rapid activation of Fos in a large number of brain areas projecting to the VTA. More than half of the CTb-Fos double-labelled neurons were located in the prefrontal cortex, lateral preoptic area-lateral hypothalamus, pontomesencephalic tegmentum, dorsal raphe nucleus, ventral pallidum and nucleus accumbens. In addition, scattered CTb-Fos double-labelled cells were observed in many other VTA afferent structures, such as claustrum, lateral septum, diagonal band-magnocellular preoptic nucleus, deep mesencephalic nucleus, oral part of pontine reticular nucleus and dorsomedial tegmental area. This suggests that systemic amphetamine activates a wide population of neurons projecting to the VTA that may be important for the modulation of neurobehavioural plasticity produced by this psychostimulant.
Colussi-Mas
Joyce
J
FRE CNRS 3006, Laboratoire de Neuropharmacologie, Université Lyon 1, 69373 Lyon Cedex 08, France.
Geisler
Stefanie
S
Zimmer
Luc
L
Zahm
Daniel S
DS
Bérod
Anne
A
D000344:Afferent Pathways / Q000166:cytology / Q000187:drug effects*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D002452:Cell Count; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D002772:Cholera Toxin / Q000494:pharmacology; D016762:Genes, fos / Q000235:genetics; D007150:Immunohistochemistry; D008297:Male; D008845:Microinjections; D009473:Neuronal Plasticity / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013268:Stimulation, Chemical; D017557:Ventral Tegmental Area / Q000166:cytology / Q000187:drug effects*
D000697:Central Nervous System Stimulants; D002772:Cholera Toxin; D000661:Amphetamine
Neuropsychopharmacology. 1990 Feb;3(1):41-50
2137698
Neurosci Lett. 1990 Nov 27;120(1):70-3
2293096
Brain Res. 1990 Nov 26;534(1-2):209-24
1705851
Brain Res. 1991 Mar 15;543(2):315-21
1676331
Pharmacol Biochem Behav. 1992 Nov;43(3):815-23
1448477
Brain Res. 1993 Mar 12;605(2):332-7
8386970
Neuroscience. 1993 Dec;57(4):1047-60
7508582
J Pharmacol Exp Ther. 1994 Aug;270(2):690-6
8071860
Brain Res. 1994 Oct 3;659(1-2):17-22
7820659
Synapse. 1995 Jan;19(1):29-36
7709341
J Pharmacol Exp Ther. 1995 Apr;273(1):445-54
7714800
Neuroscience. 1995 Mar;65(2):385-95
7777156
J Neurosci. 1995 Sep;15(9):5859-69
7666171
Neuroscience. 1995 Nov;69(2):417-39
8552239
J Neurosci. 1996 Apr 1;16(7):2411-20
8601820
J Pharmacol Exp Ther. 1996 May;277(2):1177-87
8627530
J Comp Neurol. 1996 Jan 8;364(2):254-66
8788248
Synapse. 1996 Mar;22(3):195-208
9132987
J Pharmacol Exp Ther. 1997 May;281(2):699-706
9152375
J Neurosci. 2003 Oct 22;23(29):9632-8
14573543
Neurosci Biobehav Rev. 2003 Oct;27(6):555-79
14599436
Ann N Y Acad Sci. 2003 Nov;1003:391-4
14684469
Neurosci Biobehav Rev. 2004 Jan;27(8):827-39
15019432
Brain Cogn. 2004 Jun;55(1):11-29
15134840
J Neurosci. 2004 Aug 25;24(34):7482-90
15329395
Neurosci Biobehav Rev. 1998 Mar;22(2):347-54
9579324
Neuroscience. 1998 Aug;85(4):1173-82
9681955
Eur J Neurosci. 1998 Nov;10(11):3565-71
9824469
J Neurosci. 1998 Dec 15;18(24):10579-93
9852594
Eur J Neurosci. 2004 Nov;20(10):2833-7
15548228
Neuropsychopharmacology. 2004 Dec;29(12):2115-25
15150533
J Comp Neurol. 2005 Mar 7;483(2):217-35
15678476
J Neurosci. 2005 Apr 13;25(15):3932-9
15829645
Neuropsychopharmacology. 2005 May;30(5):871-9
15637639
J Comp Neurol. 2005 Sep 26;490(3):270-94
16082674
Int J Neuropsychopharmacol. 2005 Dec;8(4):569-81
15836801
Nature. 2005 Oct 13;437(7061):1027-31
16222299
Biol Psychiatry. 2005 Nov 1;58(9):751-9
16098484
J Comp Neurol. 2006 Feb 20;494(6):863-75
16385486
Neuropsychopharmacology. 2006 Feb;31(2):384-95
15988471
Behav Brain Res. 2006 Mar 15;168(1):120-6
16313978
Neuron. 2006 Feb 16;49(4):589-601
16476667
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5167-72
16549786
CNS Neurol Disord Drug Targets. 2006 Feb;5(1):79-97
16613555
Neuropsychopharmacology. 2006 Jul;31(7):1356-61
16319915
Eur J Neurosci. 2006 Jul;24(1):116-34
16882012
Eur J Neurosci. 2007 Jan;25(1):106-18
17241272
Neuroscience. 2007 Apr 25;146(1):41-9
17321058
Neuroscience. 2007 May 25;146(3):1259-74
17391856
J Neurosci. 2007 May 23;27(21):5730-43
17522317
J Comp Neurol. 1992 Jun 8;320(2):145-60
1377716
J Neurosci. 1999 Nov 1;19(21):9579-86
10531460
Neuroscience. 1999;94(3):705-21
10579562
Pharmacol Biochem Behav. 2000 Jan 1;65(1):163-74
10638650
Cereb Cortex. 2000 Mar;10(3):326-33
10731227
J Neurosci. 2000 May 15;20(10):3864-73
10804226
J Neurosci. 2000 Jan 15;20(2):RC55
10632621
Psychopharmacology (Berl). 2000 Aug;151(2-3):99-120
10972458
Psychopharmacology (Berl). 2000 Aug;151(2-3):184-91
10972464
Nature. 2001 May 31;411(6837):583-7
11385572
Eur J Neurosci. 2001 May;13(10):1977-83
11403691
J Neurosci. 2001 Aug 15;21(16):6362-9
11487659
Neuropsychopharmacology. 2002 Jan;26(1):18-26
11751029
Neuroscience. 2002;109(3):499-516
11823062
J Neurosci. 2002 Apr 15;22(8):3269-76
11943828
Neuroscience. 2002;111(2):379-87
11983323
J Neurosci. 2002 Jun 1;22(11):4654-62
12040071
Synapse. 2002 Dec 15;46(4):240-50
12373739
Annu Rev Psychol. 2003;54:25-53
12185211
J Neurosci. 2003 Jan 1;23(1):7-11
12514194
Neuron. 2003 Feb 20;37(4):577-82
12597856
Neuroscience. 2003;118(2):311-5
12699767
Life Sci. 2003 Jun 27;73(6):759-68
12801597
Nat Neurosci. 2003 Sep;6(9):968-73
12897785
Behav Pharmacol. 2004 Sep;15(5-6):327-39
15343056
J Comp Neurol. 1979 Sep 1;187(1):117-43
489776
Brain Res. 1980 Sep 22;197(2):365-77
7407561
Brain Res. 1982 Nov 18;251(2):374-9
7139334
Brain Res. 1982 Dec 16;253(1-2):231-41
6891283
Brain Res. 1986 Jun;396(2):157-98
3527341
J Pharmacol Exp Ther. 1988 Jun;245(3):1095-102
3385638
Neuroscience. 1989;30(1):33-50
2473414
J Comp Neurol. 1989 Dec 8;290(2):213-42
2592611